Global Mice Model Genetic Engineering Market Analysis and Forecast 2026-2032
Description
The global Mice Model Genetic Engineering market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Asia-Pacific market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Mice Model Genetic Engineering include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Mice Model Genetic Engineering, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Mice Model Genetic Engineering, also provides the revenue of main regions and countries. Of the upcoming market potential for Mice Model Genetic Engineering, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mice Model Genetic Engineering revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mice Model Genetic Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Mice Model Genetic Engineering revenue, projected growth trends, production technology, application and end-user industry.
Mice Model Genetic Engineering Segment by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Mice Model Genetic Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Mice Model Genetic Engineering company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mice Model Genetic Engineering revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
The North America market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Asia-Pacific market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Mice Model Genetic Engineering include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Mice Model Genetic Engineering, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Mice Model Genetic Engineering, also provides the revenue of main regions and countries. Of the upcoming market potential for Mice Model Genetic Engineering, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mice Model Genetic Engineering revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mice Model Genetic Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Mice Model Genetic Engineering revenue, projected growth trends, production technology, application and end-user industry.
Mice Model Genetic Engineering Segment by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Mice Model Genetic Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Mice Model Genetic Engineering company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mice Model Genetic Engineering revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
219 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Mice Model Genetic Engineering Market by Type
- 1.2.1 Global Mice Model Genetic Engineering Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 CRISPR Knockout
- 1.2.3 CRISPR Knockin
- 1.2.4 Random Insertions
- 1.2.5 ES Cell Modification (homologous recombination)
- 1.2.6 Others
- 1.3 Mice Model Genetic Engineering Market by Application
- 1.3.1 Global Mice Model Genetic Engineering Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotechnology Companies
- 1.3.4 Academic & Research Facilities
- 1.3.5 Contract Research & Manufacturing Organizations
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Mice Model Genetic Engineering Market Dynamics
- 2.1 Mice Model Genetic Engineering Industry Trends
- 2.2 Mice Model Genetic Engineering Industry Drivers
- 2.3 Mice Model Genetic Engineering Industry Opportunities and Challenges
- 2.4 Mice Model Genetic Engineering Industry Restraints
- 3 Global Growth Perspective
- 3.1 Global Mice Model Genetic Engineering Market Perspective (2021-2032)
- 3.2 Global Mice Model Genetic Engineering Growth Trends by Region
- 3.2.1 Global Mice Model Genetic Engineering Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Mice Model Genetic Engineering Market Size by Region (2021-2026)
- 3.2.3 Global Mice Model Genetic Engineering Market Size by Region (2027-2032)
- 4 Competitive Landscape by Players
- 4.1 Global Mice Model Genetic Engineering Revenue by Players
- 4.1.1 Global Mice Model Genetic Engineering Revenue by Players (2021-2026)
- 4.1.2 Global Mice Model Genetic Engineering Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Mice Model Genetic Engineering Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Mice Model Genetic Engineering Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Mice Model Genetic Engineering Key Players Headquarters & Area Served
- 4.4 Global Mice Model Genetic Engineering Players, Product Type & Application
- 4.5 Global Mice Model Genetic Engineering Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Mice Model Genetic Engineering Market CR5 and HHI
- 4.6.3 2025 Mice Model Genetic Engineering Tier 1, Tier 2, and Tier 3
- 5 Mice Model Genetic Engineering Market Size by Type
- 5.1 Global Mice Model Genetic Engineering Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 5.3 Global Mice Model Genetic Engineering Revenue Market Share by Type (2021-2032)
- 6 Mice Model Genetic Engineering Market Size by Application
- 6.1 Global Mice Model Genetic Engineering Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 6.3 Global Mice Model Genetic Engineering Revenue Market Share by Application (2021-2032)
- 7 Company Profiles
- 7.1 B BIOCYTOGEN
- 7.1.1 B BIOCYTOGEN Company Information
- 7.1.2 B BIOCYTOGEN Business Overview
- 7.1.3 B BIOCYTOGEN Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.1.4 B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
- 7.1.5 B BIOCYTOGEN Recent Developments
- 7.2 Charles River Laboratories
- 7.2.1 Charles River Laboratories Company Information
- 7.2.2 Charles River Laboratories Business Overview
- 7.2.3 Charles River Laboratories Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.2.4 Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
- 7.2.5 Charles River Laboratories Recent Developments
- 7.3 Cyagen Biosciences
- 7.3.1 Cyagen Biosciences Company Information
- 7.3.2 Cyagen Biosciences Business Overview
- 7.3.3 Cyagen Biosciences Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.3.4 Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
- 7.3.5 Cyagen Biosciences Recent Developments
- 7.4 Gempharmatech
- 7.4.1 Gempharmatech Company Information
- 7.4.2 Gempharmatech Business Overview
- 7.4.3 Gempharmatech Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.4.4 Gempharmatech Mice Model Genetic Engineering Product Portfolio
- 7.4.5 Gempharmatech Recent Developments
- 7.5 genOway
- 7.5.1 genOway Company Information
- 7.5.2 genOway Business Overview
- 7.5.3 genOway Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.5.4 genOway Mice Model Genetic Engineering Product Portfolio
- 7.5.5 genOway Recent Developments
- 7.6 ingenious targeting laboratory
- 7.6.1 ingenious targeting laboratory Company Information
- 7.6.2 ingenious targeting laboratory Business Overview
- 7.6.3 ingenious targeting laboratory Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.6.4 ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
- 7.6.5 ingenious targeting laboratory Recent Developments
- 7.7 Ozgene Pty Ltd.
- 7.7.1 Ozgene Pty Ltd. Company Information
- 7.7.2 Ozgene Pty Ltd. Business Overview
- 7.7.3 Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.7.4 Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
- 7.7.5 Ozgene Pty Ltd. Recent Developments
- 7.8 Taconic Biosciences, Inc.
- 7.8.1 Taconic Biosciences, Inc. Company Information
- 7.8.2 Taconic Biosciences, Inc. Business Overview
- 7.8.3 Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.8.4 Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
- 7.8.5 Taconic Biosciences, Inc. Recent Developments
- 7.9 PolyGene AG
- 7.9.1 PolyGene AG Company Information
- 7.9.2 PolyGene AG Business Overview
- 7.9.3 PolyGene AG Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.9.4 PolyGene AG Mice Model Genetic Engineering Product Portfolio
- 7.9.5 PolyGene AG Recent Developments
- 7.10 THE JACKSON LABORATORY
- 7.10.1 THE JACKSON LABORATORY Company Information
- 7.10.2 THE JACKSON LABORATORY Business Overview
- 7.10.3 THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.10.4 THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
- 7.10.5 THE JACKSON LABORATORY Recent Developments
- 7.11 Yale School of Medicine
- 7.11.1 Yale School of Medicine Company Information
- 7.11.2 Yale School of Medicine Business Overview
- 7.11.3 Yale School of Medicine Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.11.4 Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
- 7.11.5 Yale School of Medicine Recent Developments
- 7.12 University of North Carolina
- 7.12.1 University of North Carolina Company Information
- 7.12.2 University of North Carolina Business Overview
- 7.12.3 University of North Carolina Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.12.4 University of North Carolina Mice Model Genetic Engineering Product Portfolio
- 7.12.5 University of North Carolina Recent Developments
- 7.13 University of Nebraska Medical Center
- 7.13.1 University of Nebraska Medical Center Company Information
- 7.13.2 University of Nebraska Medical Center Business Overview
- 7.13.3 University of Nebraska Medical Center Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.13.4 University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
- 7.13.5 University of Nebraska Medical Center Recent Developments
- 7.14 Monash University
- 7.14.1 Monash University Company Information
- 7.14.2 Monash University Business Overview
- 7.14.3 Monash University Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.14.4 Monash University Mice Model Genetic Engineering Product Portfolio
- 7.14.5 Monash University Recent Developments
- 7.15 UMass Chan Medical School
- 7.15.1 UMass Chan Medical School Company Information
- 7.15.2 UMass Chan Medical School Business Overview
- 7.15.3 UMass Chan Medical School Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.15.4 UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
- 7.15.5 UMass Chan Medical School Recent Developments
- 7.16 University of Bonn
- 7.16.1 University of Bonn Company Information
- 7.16.2 University of Bonn Business Overview
- 7.16.3 University of Bonn Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.16.4 University of Bonn Mice Model Genetic Engineering Product Portfolio
- 7.16.5 University of Bonn Recent Developments
- 7.17 Columbia University
- 7.17.1 Columbia University Company Information
- 7.17.2 Columbia University Business Overview
- 7.17.3 Columbia University Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.17.4 Columbia University Mice Model Genetic Engineering Product Portfolio
- 7.17.5 Columbia University Recent Developments
- 7.18 The University of Arizona
- 7.18.1 The University of Arizona Company Information
- 7.18.2 The University of Arizona Business Overview
- 7.18.3 The University of Arizona Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.18.4 The University of Arizona Mice Model Genetic Engineering Product Portfolio
- 7.18.5 The University of Arizona Recent Developments
- 7.19 The Weizmann Institute of Science
- 7.19.1 The Weizmann Institute of Science Company Information
- 7.19.2 The Weizmann Institute of Science Business Overview
- 7.19.3 The Weizmann Institute of Science Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.19.4 The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
- 7.19.5 The Weizmann Institute of Science Recent Developments
- 7.20 The Hebrew University of Jerusalem
- 7.20.1 The Hebrew University of Jerusalem Company Information
- 7.20.2 The Hebrew University of Jerusalem Business Overview
- 7.20.3 The Hebrew University of Jerusalem Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.20.4 The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
- 7.20.5 The Hebrew University of Jerusalem Recent Developments
- 7.21 The Technion – Israel Institute of Technology
- 7.21.1 The Technion – Israel Institute of Technology Company Information
- 7.21.2 The Technion – Israel Institute of Technology Business Overview
- 7.21.3 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.21.4 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
- 7.21.5 The Technion – Israel Institute of Technology Recent Developments
- 7.22 Hadassah BrainLabs
- 7.22.1 Hadassah BrainLabs Company Information
- 7.22.2 Hadassah BrainLabs Business Overview
- 7.22.3 Hadassah BrainLabs Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.22.4 Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
- 7.22.5 Hadassah BrainLabs Recent Developments
- 8 North America
- 8.1 North America Mice Model Genetic Engineering Revenue (2021-2032)
- 8.2 North America Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 8.2.1 North America Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 8.2.2 North America Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 8.3 North America Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 8.4 North America Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 8.4.1 North America Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 8.4.2 North America Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 8.5 North America Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 8.6 North America Mice Model Genetic Engineering Revenue by Country
- 8.6.1 North America Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 8.6.3 North America Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
- 9 Europe
- 9.1 Europe Mice Model Genetic Engineering Revenue (2021-2032)
- 9.2 Europe Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 9.2.1 Europe Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 9.2.2 Europe Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 9.3 Europe Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 9.4 Europe Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 9.4.1 Europe Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 9.4.2 Europe Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 9.5 Europe Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 9.6 Europe Mice Model Genetic Engineering Revenue by Country
- 9.6.1 Europe Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 9.6.3 Europe Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
- 10 China
- 10.1 China Mice Model Genetic Engineering Revenue (2021-2032)
- 10.2 China Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 10.2.1 China Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 10.2.2 China Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 10.3 China Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 10.4 China Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 10.4.1 China Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 10.4.2 China Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 10.5 China Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 11 Asia (Excluding China)
- 11.1 Asia Mice Model Genetic Engineering Revenue (2021-2032)
- 11.2 Asia Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 11.2.1 Asia Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 11.2.2 Asia Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 11.3 Asia Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 11.4 Asia Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 11.4.1 Asia Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 11.4.2 Asia Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 11.5 Asia Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 11.6 Asia Mice Model Genetic Engineering Revenue by Country
- 11.6.1 Asia Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 11.6.3 Asia Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Mice Model Genetic Engineering Revenue (2021-2032)
- 12.2 SAMEA Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 12.2.1 SAMEA Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 12.2.2 SAMEA Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 12.3 SAMEA Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 12.4 SAMEA Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 12.4.1 SAMEA Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 12.4.2 SAMEA Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 12.5 SAMEA Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 12.6 SAMEA Mice Model Genetic Engineering Revenue by Country
- 12.6.1 SAMEA Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 12.6.3 SAMEA Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



